Tumor Agnostic Treatments: A new era in Oncology Drug Discovery
Tumor-agnostic treatments have come into prominence as a cutting-edge new method of treating cancer in an era where precision...
RNAi therapy under investigation in alpha1 antitrypsin deficiency liver disease
Patients with a genetic disease called alpha1 antitrypsin deficiency can develop both liver disease and lung disease, either of...
A unique thymocyte cell that, in certain people, develops into leukaemia
Scientists from the University of Missouri School of Medicine and College of Engineering described the thymocyte cells, an immune...
Recent review: A Peep in the world of Diabetes.
The medical literature on diabetes research, both in terms of development and management, is intriguing.There was a recent study...
Why is Hellen Keller’s name inscribed in gilded letters in the annals of deaf and blind awareness?
In 1984, President Ronald Reagan labeled the last week of June as Helen Keller Deaf-Blind Awareness Week. Every year,...
Starting early with microbiome health
Our gut microbes do a lot for us. They generate vitamins, help protect us from infections, and help regulate...
Arthritis: Raise awareness for a better tomorrow
Arthritis Awareness Month is an important opportunity to reflect on the impact that arthritis has on people who live...
Why does the memory of fear stick with us?
The researchers from Tulane University found that the stress neurotransmitter norepinephrine, commonly known as noradrenaline, increases fear processing in...
US Preventive Services Task Force downgrades daily aspirin use in cardiovascular disease prevention
For decades, some doctors and practice guidelines have recommended that older adults take low-dose aspirin daily for primary cardiovascular...
SYK inhibitor showing potential in treating warm autoimmune hemolytic anemia
Spleen tyrosine kinase inhibitors are a family of molecules that target a protein, SYK, that’s important in immune signaling.1...